Lopressor and Oesophagitis aggravated - a phase IV clinical study of FDA data

Summary:

Oesophagitis aggravated is reported as a side effect among people who take Lopressor (metoprolol tartrate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zoloft, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Oesophagitis aggravated when taking Lopressor. It is created by eHealthMe based on reports of 32,072 people who have side effects when taking Lopressor from the FDA, and is updated regularly.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

What is Oesophagitis aggravated?

Oesophagitis aggravated (inflammation of oesophagus) is found to be associated with 970 drugs and 378 conditions by eHealthMe. Check the latest studies of Oesophagitis aggravated.

On Jul, 17, 2026

32,072 people reported to have side effects when taking Lopressor.
Among them, 137 people (0.43%) have Oesophagitis aggravated.

Could Lopressor cause Oesophagitis aggravated?

Among these 137 people:

How long have people been on Lopressor when they have Oesophagitis aggravated? *

Click here to view more results

What is the gender of people who have Oesophagitis aggravated when taking Lopressor? *

Click here to view

What is the age of people who have Oesophagitis aggravated when taking Lopressor? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Lopressor and have Oesophagitis aggravated?

- Check whether Oesophagitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopressor:

Lopressor (33,152 reports)

Oesophagitis aggravated treatments and more:

Oesophagitis aggravated (34 reports)

How severe was Oesophagitis aggravated and when was it recovered:

Oesophagitis aggravated in Lopressor

Expand to all the drugs that have ingredients of metoprolol tartrate:

Oesophagitis aggravated and drugs with ingredients of metoprolol tartrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oesophagitis aggravated:

Oesophagitis aggravated (970 drugs)

Browse all the conditions that are associated with Oesophagitis aggravated:

Oesophagitis aggravated (378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Lopressor) and Lopressor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.